Biotech Rout Not Surprising: Surveying The Damage
Top Ten Reasons For Biotech Correction NASDAQ at 4022,IBB at 221 A Sentiment Driven Market We have been writing about the bull market in biotech stocks since its inception in March 2009 when quality companies were advancing their pipelines and new products in immunology, oncology and infectious...
Risk Reversal: Bargain Hunting and FOMC Catalyst Perks Up Biotech Stocks… Update-1
Update 4/10 Abrupt Sell-Off --Failure to Confirm Bottom NASDAQ down 71 pts 1.7% All of yesterdays' gains wiped out and we are back to January levels. Raise cash levels to 30% on life science portfolios. Many high fliers and core holdings are selling off today after bullish action yesterday....
Seeking A Technical Bottom For Biotech Stocks….. Update 4/9 Rally
NASDAQ Up 0.37% to 4133 Green screen alert with large cap biotechs. Time to cover hedges. Alexion (ALXN) up 2.23% Biogen (BIIB) Up 2.4% Celgene (CELG) up 3.61% Clovis Oncology (CLVS) up 2.85% Gilead (GILD) up 1.35% IBB up 1.96% Regeneron (REGN) up 3.99% Key Trends To Watch: April Update After...
Rayno Life Science: Tools and Diagnostics Q1 2014 Performance
Caution As Life Science Stocks Are Consolidating Life science stocks had a wild roller coaster ride in 2014 with many stocks peaking around March 1. Momentum and cult stocks in our portfolio still had a good quarter with the following top winners: Illumina (ILMN) up 25.2%, Vermillion (VRML) up...
Biotech Sell-Off Resumes: Caution Update 4/4
Update 4/4/14 Breach of Technicals-A Tad Below Early February Support Glut of Biotech IPOs Causing Indigestion? Momentum Days Are So Over NASDAQ Down 1.34% The volatile and speculative SPDR S&P Biotech XBI hit $136 in early trading down 2.28%.After a brief rally early this week to the $148...